NEW YORK (GenomeWeb News) – Shares in Third Wave Technologies were up 13 percent, or $.31, at $2.66 in mid-afternoon trading today after the company said second-quarter revenues increased while net loss narrowed.
As GenomeWeb News reported this morning, Third Wave said revenues increased approximately 17 percent and net losses declined. Clinical molecular diagnostic receipts jumped 18 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.